Dr. Nasrazadani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcolme Blvd, Unit 1354
Houston, TX 77030Phone+1 713-792-2817Fax+1 713-794-4385
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2017 - 2020
- UPMC Medical EducationResidency, Internal Medicine, 2015 - 2017
- Texas Tech University Health Sciences Center Paul L. Foster School of MedicineClass of 2015
- University of Texas at Austin PhD, Pharmacology, 2010
Certifications & Licensure
- FL State Medical License 2024 - Present
- TX State Medical License 2021 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Gianni Bonadonna Breast Cancer Research Fellowship American Society of Clinical Oncology (ASCO), 2019
Publications & Presentations
PubMed
- Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer.Xiaoping Wang, Li Zhao, Xingzhi Song, Xiaogang Wu, Savitri Krishnamurthy
NPJ Precision Oncology. 2024-11-18 - Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions.Xiaoxin Hao, Yichao Shen, Jun Liu, Angela Alexander, Ling Wu
Nature Cell Biology. 2024-11-01 - 2 citationsSpatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutati...Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer
Proceedings of the National Academy of Sciences of the United States of America. 2024-07-30
Books/Book Chapters
Abstracts/Posters
- Mixed invasive ductal and lobular carcinoma (IDC/L) behaves similarly to invasive lobular carcinoma (ILC) with regard to neoadjuvant chemotherapy response and metastat...Nasrazadani A, Atkinson JM, Li Y, McAuliffe PF, Jankowitz RC, Emens LA, Tseng GC, Lee AV, Wolmark NW, Oesterreich S, Lucas PC, Cancer Res 2020;80(4 Suppl):Abstract nr P2-16-26.
- Metastatic behavior of mixed invasive ductal lobular carcinoma (mIDC/ILC)Nasrazadani A, Li Y, Tseng GC, Xavier J, Lee AV, Lucas PC, Oesterreich S, Wolmark NW, Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 1085-1085.
- Mixed Invasive Ductal-Lobular Carcinoma – Clinicopathological characterization and clinical outcomesNasrazadani A, Li Y, Tseng G, McAuliffe P, Xavier J, Hugar S, Lee AV, Lucas P, Jankowitz R, Oesterreich S, Journal of Clinical Oncology 2019 37:15_suppl, e12531-e12531
- Join now to see all
Lectures
- A Current Data on the Reduction in Risk of Developing New Brain Lesions in HER2+ MBC: What Differentiates Tucatinib From Other TKIs?6/11/2021
- Dentin Matrix Protein 1 and C-Jun N-terminal Kinase: Potential Players in Breast Cancer Mediated Bone MetastasisGCSOT Annual Meeting 2007, College Station, TX
Other
- Accuracy of Ki-67 with Recurrence Score and Recurrence Score -Pathology - Clinical Assessment in Early Stage Breast CancerA Nasrazadani, A Dwivedi, S Otoukesh, O Padilla, A Alvarado, LA Sanchez, A Tfayli, and Z Nahleh, Hematol Oncol. 2014;1(3): 6.
- Statins and Endocrine Resistance in Breast CancerTara Hyder, Juan Luis Gomez Marti, Azadeh Nasrazadani, Adam M. Brufsky, Cancer Drug Resist 2021;4
https://cdrjournal.com/article/view/3885
1/25/2021
Authored Content
- Margetuximab improves PFS in HER2-positive metastatic breast cancerJune 2019
- Protocol for Immunohistochemistry on Mouse SpineOctober 2007
Press Mentions
- When Tumors Collide: Analysis of Mixed-Type Breast Cancer Reveals ComplexityJuly 23rd, 2024
- New Treatments for Metastatic Breast CancerDecember 20th, 2022
- Breast Cancer Survivor: ‘MD Anderson Is a Healing Mecca’July 27th, 2023
Grant Support
- Magee Women's Cancer Research & Education Funding in MBC ResearchMagee Women’s Research Institute and the Hillman Cancer Center2021–2022
- Gianni Bonadonna Breast Cancer Research FellowshipConquer Cancer Foundation of the American Society of Clinical Oncology2019–2020
- DoD predoctoral grantDepartment of Defense Breast Cancer Research Program2008–2011
Committees
- Board Member, One Day to Remember 2022 - Present
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: